<VariationArchive VariationID="2427643" VariationName="NC_000005.9:g.(?_1282603)_(1283866_?)del" VariationType="Deletion" Accession="VCV002427643" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1951889" VariationID="2427643">
      <GeneList>
        <Gene Symbol="TERT" FullName="telomerase reverse transcriptase" GeneID="7015" HGNC_ID="HGNC:11730" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p15.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="1253167" stop="1295068" display_start="1253167" display_stop="1295068" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="1253281" stop="1295161" display_start="1253281" display_stop="1295161" Strand="-" />
          </Location>
          <OMIM>187270</OMIM>
          <Haploinsufficiency last_evaluated="2011-11-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TERT">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2011-11-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TERT">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.9:g.(?_1282603)_(1283866_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5p15.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="1282603" innerStop="1283866" display_start="1282603" display_stop="1283866" variantLength="1264" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_1282603)_(1283866_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_1282603)_(1283866_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.9:g.(?_1282603)_(1283866_?)del AND multiple conditions" Accession="RCV003113973" Version="3">
        <ClassifiedConditionList TraitSetID="82309">
          <ClassifiedCondition DB="MedGen" ID="C3151443">Dyskeratosis congenita, autosomal dominant 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1800706">Idiopathic Pulmonary Fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16247010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17460043</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23538340</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="82309" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Idiopathic fibrosing alveolitis, chronic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Idiopathic Pulmonary Fibrosis</ElementValue>
                <XRef ID="700250006" DB="SNOMED CT" />
              </Name>
              <XRef ID="C1800706" DB="MedGen" />
              <XRef ID="D054990" DB="MeSH" />
            </Trait>
            <Trait ID="16124" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 2</ElementValue>
                <XRef ID="MONDO:0013521" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA2</ElementValue>
                <XRef Type="MIM" ID="613989" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15741" />
                <XRef ID="15741" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3151443" DB="MedGen" />
              <XRef ID="MONDO:0013521" DB="MONDO" />
              <XRef Type="MIM" ID="613989" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7076667" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_198253.2_5_Partial deletion (exon 3)_1282602_1283866|MedGen:C3151443;C1800706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003795273" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16247010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17460043</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23538340</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 3 (c.1574-1127_1710delinsTCCGGTAGAAAAG) of the TERT gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TERT are known to be pathogenic (PMID: 16247010, 17460043). This variant has not been reported in the literature in individuals affected with TERT-related conditions. This variant disrupts a region of the TERT protein in which other variant(s) (p.Thr567Met) have been determined to be pathogenic (PMID: 23538340; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TERT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_1282603)_(1283866_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151443" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1800706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7076667" TraitType="Disease" MappingType="XRef" MappingValue="C1800706" MappingRef="MedGen">
        <MedGen CUI="C1800706" Name="Idiopathic Pulmonary Fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7076667" TraitType="Disease" MappingType="XRef" MappingValue="C3151443" MappingRef="MedGen">
        <MedGen CUI="C3151443" Name="Dyskeratosis congenita, autosomal dominant 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

